ArticleBioengineering & translational medicine2021

Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer.

Debra Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.